Syros Pharmaceuticals (SYRS) Earnings
|
Expand Research on SYRS
| Next EPS Date | 5/2/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -13.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/2/24 | Q124 | N/A | -$0.85 | N/A | N/A | $900K | N/A | N/A | N/A | ||
| 3/12/24 | Q423 | N/A | -$1.14 | N/A | N/A | $2M | N/A | N/A | N/A | ||
| 3/18/24 | Q423 | N/A | -$1.14 | N/A | N/A | $2M | N/A | N/A | N/A | ||
3/27/24  |
Q423 | N/A | -$1.14 | N/A | N/A | $2M | N/A | N/A | N/A | ||
| 11/6/23 | Q323 | N/A | -$1.14 | N/A | N/A | $3.94M | N/A | N/A | N/A | ||
| 11/3/23 | Q323 | N/A | -$1.14 | N/A | N/A | $3.94M | N/A | N/A | N/A | ||
| 11/14/23 | Q323 | -$1.43 | -$1.14 | -$0.29 | $3.76M | $3.94M | N/A |  | | Details | |
| 8/8/23 | Q223 | -$1.30 | -$1.13 | -$0.17 | $2.8M | $3.5M | N/A | | | Details |
